Propel Bio Management, LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1969764
LOS ANGELES, CA
Position in VRDN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,110,788
-$4,681,576 QoQ
Shares Held
210,163
-25.6% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Propel Bio Management, LLC holds $135,066,196 across 34 Biotechnology names. VRDN ranks #10 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMUX |
Immunic, Inc.
|
2,344,779 | $26,027,046 | |
| 2 | ACHV |
Achieve Life Sciences, Inc.
|
3,786,425 | $11,132,089 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
841,272 | $9,346,531 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
147,828 | $5,958,946 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
1,329,899 | $5,957,947 | |
| 6 | VOR |
Vor Biopharma Inc.
|
314,543 | $5,611,447 | |
| 7 | KYTX |
Kyverna Therapeutics, Inc.
|
644,421 | $5,561,353 | |
| 8 | MIST |
Milestone Pharmaceuticals Inc.
|
4,118,321 | $4,900,801 |
All Filings in VRDN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,110,788 | 210,163 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,792,364 | 282,531 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,942,200 | 90,000 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||